Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 27;21(1):1010.
doi: 10.1186/s12879-021-06697-1.

Infective endocarditis in intravenous drug abusers: clinical challenges emerging from a single-centre experience

Valentina Scheggi  1 , Stefano Del Pace  2 , Nicole Ceschia  2 , Francesco Vanni  2 , Irene Merilli  3 , Edoardo Sottili  2 , Leonardo Salcuni  2 , Nicola Zoppetti  4 , Bruno Alterini  3 , Alfredo Cerillo  5 , Niccolò Marchionni  2   6 , Pier Luigi Stefàno  5   6
Affiliations

Infective endocarditis in intravenous drug abusers: clinical challenges emerging from a single-centre experience

Valentina Scheggi et al. BMC Infect Dis. .

Abstract

Background: Intravenous drug abuse (IDA) is a known risk factor for infective endocarditis (IE) and is associated with frequent relapses, but its prognostic impact is still debated. The potential futility of surgery in this population is a further issue under discussion. We aimed to describe the clinical characteristics, the therapeutic strategy, and the prognosis associated with IDA in IE.

Methods: We retrospectively analysed 440 patients admitted to a single surgical centre for definite active IE from January 2012 to December 2020.

Results: Patients reporting IDA (N = 54; 12.2%) were significantly younger (p < 0.001) and presented fewer comorbidities (p < 0.001). IDA was associated with a higher proportion of relapses (27.8 vs. 3.3%, p < 0.001) and, at multivariable analysis, was an independent predictor of long-term mortality (HR 2.3, 95%CI 1.1-4.7, p = 0.015). We did not register multiple relapses in non-IDA patients. Among IDA patients, we observed 1 relapse after discharge in 9 patients, 2 relapses in 5 patients and 3 relapses in 1 patient. In IDA patients, neither clinical and laboratory variables nor the occurrence of even multiple relapses emerged as indicators of an adverse risk-benefit ratio of surgery in patients with surgical indication.

Conclusions: IE secondary to IDA affects younger patients than those with IE not associated with IDA. Probably due to this difference, IE secondary to IDA is not associated with significantly higher mortality, whereas the negative, long-term prognostic impact of IDA emerges in multivariate analysis. Considering the good prognosis of patients with uncomplicated IE treated medically, surgery should be reserved to patients with a strict- guidelines-based indication. However, since there are no clear predictors of an unfavourable risk-benefit ratio of surgery in patients with surgical indication, all patients with a complicated IE should be operated, irrespective of a history of IDA.

Keywords: Cardiac surgery; Infective endocarditis; Intravenous drug abuse; Prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Kaplan–Meier survival analysis of 440 patients with infective endocarditis associated and non-associated with intravenous drug abuse (IDA)
See this image and copyright information in PMC

References

    1. Rudasill SE, Sanaiha Y, Mardock AL, Khoury H, Xing H, Antonios JW, McKinnell JA, et al. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019;73(5):559–570. doi: 10.1016/j.jacc.2018.10.082. - DOI - PubMed
    1. Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis. 2000;30(2):374–379. doi: 10.1086/313664. - DOI - PubMed
    1. Rohn V, Laca B, Horn M, Vlk L, Antonova P, Mosna F. Surgery in drug use-associated infective endocarditis: long-term survival is negatively affected by recurrence. Interact Cardiovasc Thorac Surg. 2020;30(4):528–534. doi: 10.1093/icvts/ivz302. - DOI - PubMed
    1. Shrestha NK, Jue J, Hussain ST, Jerry JM, Pettersson GB, Menon V, et al. Injection drug use and outcomes after surgical intervention for infective endocarditis. Ann Thorac Surg. 2015;100(3):875–882. doi: 10.1016/j.athoracsur.2015.03.019. - DOI - PubMed
    1. Rodger L, Glockler-Lauf SD, Shojaei E, Sherazi A, Hallam B, Koivu S, et al. Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs. JAMA Netw Open. 2018;1(7):e185220. doi: 10.1001/jamanetworkopen.2018.5220. - DOI - PMC - PubMed